Literature DB >> 16012191

Computer-assisted image analysis of caveolin-1 involvement in the internalization process of adenosine A2A-dopamine D2 receptor heterodimers.

Susanna Genedani1, Diego Guidolin, Giuseppina Leo, Monica Filaferro, Maria Torvinen, Amina S Woods, Kjell Fuxe, Sergi Ferré, Luigi F Agnati.   

Abstract

A functional aspect of horizontal molecular networks has been investigated experimentally, namely the heteromerization between adenosine A2A and dopamine D2 receptors and the possible role of caveolin-1 in the co-trafficking of these molecular complexes. This study has been carried out by means of computer-assisted image analysis procedure of laser images of membrane immunoreactivity of caveolin-1, A2A, D1, and D2 receptors obtained in two clones of Chinese hamster ovary cells one transfected with A2A and dopamine D1 receptors and the other one with A2A and D2 receptors. Cells were treated for 3 h with 10 microM D1 receptor agonist SKF 38393, 50 microM D2-D3 receptor agonist quinpirole, and 200 nM A2A receptor agonist CGS 21680. In A2A-D1-cotransfected cells, caveolin-1 was found to colocalize with both A2A and D1 receptors and treatment with SKF 38393 induced internalization of caveolin-1 and D1 receptors, with a preferential internalization of D1 receptors colocalized with caveolin-1. In A2A-D2-cotransfected cells, caveolin-1 was found to colocalize with both A2A and D2 receptors and either CGS 21680 or quinpirole treatment induced internalization of caveolin-1 and A2A and D2 receptors, with a preferential internalization of A2A and D2 receptors colocalized with caveolin-1. The results suggest that A2A and D2 receptors and caveolin-1 likely interact forming a macrocomplex that internalizes upon agonist treatment. These observations are discussed in the frame of receptor oligomerization and of the possible functional role of caveolin-1 in the process of co-internalization and, hence, in controlling the permanence of receptors at the plasma membrane level (prerequisite for receptor mosaic organization and plastic adjustments) and in the control of receptor desensitization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16012191     DOI: 10.1385/JMN:26:2-3:177

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  36 in total

Review 1.  Caveolins, liquid-ordered domains, and signal transduction.

Authors:  E J Smart; G A Graf; M A McNiven; W C Sessa; J A Engelman; P E Scherer; T Okamoto; M P Lisanti
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  Deconvolution improves colocalization analysis of multiple fluorochromes in 3D confocal data sets more than filtering techniques.

Authors:  L Landmann
Journal:  J Microsc       Date:  2002-11       Impact factor: 1.758

3.  Dopamine D2 receptor dimer formation: evidence from ligand binding.

Authors:  D Armstrong; P G Strange
Journal:  J Biol Chem       Date:  2001-02-23       Impact factor: 5.157

Review 4.  Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons.

Authors:  Luigi F Agnati; Sergi Ferré; Carme Lluis; Rafael Franco; Kjell Fuxe
Journal:  Pharmacol Rev       Date:  2003-07-17       Impact factor: 25.468

Review 5.  The caveolae membrane system.

Authors:  R G Anderson
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

6.  Reciprocal interactions between adenosine A2A and dopamine D2 receptors in Chinese hamster ovary cells co-transfected with the two receptors.

Authors:  B Kull; S Ferré; G Arslan; P Svenningsson; K Fuxe; C Owman; B B Fredholm
Journal:  Biochem Pharmacol       Date:  1999-09-15       Impact factor: 5.858

7.  Sensitization of neuronal A2A adenosine receptors after persistent D2 dopamine receptor activation.

Authors:  Timothy A Vortherms; Val J Watts
Journal:  J Pharmacol Exp Ther       Date:  2003-10-17       Impact factor: 4.030

8.  Biochemical identification of the dopamine D2 receptor domains interacting with the adenosine A2A receptor.

Authors:  Maria Torvinen; Laura B Kozell; Kim A Neve; Luigi F Agnati; Kjell Fuxe
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

9.  Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias.

Authors:  Frédéric Calon; Mehdi Dridi; Oleh Hornykiewicz; Paul J Bédard; Ali H Rajput; Thérèse Di Paolo
Journal:  Brain       Date:  2004-03-19       Impact factor: 13.501

10.  Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer.

Authors:  Meritxell Canals; Daniel Marcellino; Francesca Fanelli; Francisco Ciruela; Piero de Benedetti; Steven R Goldberg; Kim Neve; Kjell Fuxe; Luigi F Agnati; Amina S Woods; Sergi Ferré; Carme Lluis; Michel Bouvier; Rafael Franco
Journal:  J Biol Chem       Date:  2003-08-21       Impact factor: 5.157

View more
  14 in total

1.  CRM197-induced blood-brain barrier permeability increase is mediated by upregulation of caveolin-1 protein.

Authors:  Ping Wang; Yunhui Liu; Xiuli Shang; Yixue Xue
Journal:  J Mol Neurosci       Date:  2010-11-16       Impact factor: 3.444

2.  Differential sensitivity of A2A and especially D2 receptor trafficking to cocaine compared with lipid rafts in cotransfected CHO cell lines. Novel actions of cocaine independent of the DA transporter.

Authors:  Susanna Genedani; Chiara Carone; Diego Guidolin; Monica Filaferro; Daniel Marcellino; Kjell Fuxe; Luigi Francesco Agnati
Journal:  J Mol Neurosci       Date:  2010-02-09       Impact factor: 3.444

3.  Identification of two functionally distinct endosomal recycling pathways for dopamine D₂ receptor.

Authors:  Yun Li; Brittany D Roy; Wei Wang; Li Zhang; Lifeng Zhang; Stephen B Sampson; Yupeng Yang; Da-Ting Lin
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

Review 4.  Regulation of monoamine transporters and receptors by lipid microdomains: implications for depression.

Authors:  Joanne J Liu; Adrienne Hezghia; Saame Raza Shaikh; Joshua F Cenido; Ruth E Stark; J John Mann; M Elizabeth Sublette
Journal:  Neuropsychopharmacology       Date:  2018-06-28       Impact factor: 7.853

5.  Caveolin-1 regulation of disrupted-in-schizophrenia-1 as a potential therapeutic target for schizophrenia.

Authors:  Adam Kassan; Junji Egawa; Zheng Zhang; Angels Almenar-Queralt; Quynh My Nguyen; Yasaman Lajevardi; Kaitlyn Kim; Edmund Posadas; Dilip V Jeste; David M Roth; Piyush M Patel; Hemal H Patel; Brian P Head
Journal:  J Neurophysiol       Date:  2016-11-02       Impact factor: 2.714

6.  Interrelation of dopamine transporter oligomerization and surface presence as studied with mutant transporter proteins and amphetamine.

Authors:  Yan Li; Shu-Yuan Cheng; Nianhang Chen; Maarten E A Reith
Journal:  J Neurochem       Date:  2010-05-18       Impact factor: 5.372

Review 7.  Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease.

Authors:  Joanne J Liu; Pnina Green; J John Mann; Stanley I Rapoport; M Elizabeth Sublette
Journal:  Brain Res       Date:  2014-12-08       Impact factor: 3.252

8.  Molecular determinants of A2AR-D2R allosterism: role of the intracellular loop 3 of the D2R.

Authors:  Víctor Fernández-Dueñas; Maricel Gómez-Soler; Kenneth A Jacobson; Santhosh T Kumar; Kjell Fuxe; Dasiel O Borroto-Escuela; Francisco Ciruela
Journal:  J Neurochem       Date:  2012-09-28       Impact factor: 5.372

9.  Polyunsaturated fatty acid associations with dopaminergic indices in major depressive disorder.

Authors:  M Elizabeth Sublette; Hanga C Galfalvy; Joseph R Hibbeln; John G Keilp; Kevin M Malone; Maria A Oquendo; J John Mann
Journal:  Int J Neuropsychopharmacol       Date:  2013-12-03       Impact factor: 5.176

10.  Substrates dissociate dopamine transporter oligomers.

Authors:  Nianhang Chen; Maarten E A Reith
Journal:  J Neurochem       Date:  2007-12-18       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.